why choose us

First received: September 14, 2022

Clinical Trial: Evaluate REC-4881 in Patients With FAP

Study Status: Completed

Recruit Status: RECRUITING

Condition: Familial Adenomatous Polyposis

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Trial to Evaluate Efficacy, Safety, and Pharmacokinetics, and Pharmacodynamics of REC-4881 in Patients With Familial Adenomatous Polyposis (FAP)

Brief Summary: This is a multicenter, two-part trial in participants with Familial Adenomatous Polyposis (FAP).

Read more